C12Y 301/27003
Ribonuclease t1
Official title: Ribonuclease T1 (3.1.27.3)
C12Y301/27003 (Ribonuclease t1) appears on 8 US grants and 2 published applications in this corpus.
Search patents in C12Y- Granted patents
- 8
- Published applications
- 2
- Assignees
- 7
- Inventors
- 12
- Latest grant
- 13 Oct 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 0 |
| 2003 | 1 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer13 Oct 2020US 10,800,828 B2The Scripps Research Institute
- Hybrid seed production27 Jan 2004US 6,683,230 B1Syngenta Limited
- Plants with modified stamen cells30 Sep 2003US 6,627,799 B1Bayer BioScience N. V.
- Plants with modified stamen cells16 Apr 2002US 6,372,967 B1Aventis CropScience GmbH
- Plants with modified stamen cells5 Feb 2002US 6,344,598 B1
Most cited
By later US patents
- Plants with modified stamen cells11US 6,372,967 B1Aventis CropScience GmbH · 2002
- Stamen-selective promoters7US 5,652,354 APlant Genetic Systems, N.V. · 1997
- Plants with modified stamen cells6US 6,627,799 B1Bayer BioScience N. V. · 2003
- Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer2US 10,800,828 B2The Scripps Research Institute · 2020
- Hybrid seed production2US 6,683,230 B1Syngenta Limited · 2004